1. Introduction
Radiotherapy is essential for cancer treatment to kill cancer cells and shrink tumors [
1], while it remains an intractable challenge to eradicate tumors and reduce the side effects to healthy tissue. Bone tissue is often involved during local radiotherapy treatments because of its unique distribution in the body, leading to a deleterious effect on the bone metabolism and microstructure, which increases the risk of bone loss and pathological fractures, as well as tumor bone metastasis due to bone matrix damage [
2,
3,
4,
5]. However, the deleterious effects of irradiation on healthy bone tissue and the resulting radiation damage mechanisms are poorly understood. Furthermore, as survival rates improve and cancer patients live longer, the combination of therapy-induced senescence (TIS) and physiological senescence in tumor-prone age groups can exacerbate bone loss and structural damage in irradiated areas and even throughout the entire body [
6,
7,
8].
Studies have shown that ionizing radiation (IR) directly affects cells’ activity and repopulation capacity, resulting in deteriorated bone formations with cell cycle arrest and direct cell death [
9,
10]. Meanwhile, IR can prompt oxidative stress, DNA damage, and cellular apoptosis [
11], leading to a senescent state in most cell types within the bone microenvironment and to the development of a heterogeneous senescence-associated secretory phenotype (SASP) [
12,
13], commonly referred to as stress-induced premature senescence (SIPS) [
7]. The pathological accumulation of senescent cells (SNCs) is implicated in the generation of a pro-inflammatory secretome or SASP, subsequently promoting secondary senescence and tissue homeostasis disruption [
14,
15,
16]. The level of SASP relies on the positive feedback loop of autocrine and paracrine, resulting in a cascade amplification effect [
13,
15].
Osteocytes (OCYs), former osteoblasts that are encapsulated by a mineralized bone matrix, are multifunctional and dynamic cells that are capable of integrating hormonal and mechanical signals and transmitting them to effector cells in bone and other distant tissues. They also play a crucial role in maintaining skeletal homeostasis [
17,
18,
19,
20,
21]. Senescent OCYs, as one of the main SASP-secreting cell types in the bone microenvironment [
22], and diverse SASPs may contribute to senescence-related bone matrix disintegration and bone loss [
23]. Studies have revealed that aging is linked to OCY dysfunction, with degeneration being observed in the OCY lacuna-canalicular network in both older adults and aging animal models [
24,
25]. Furthermore, the accumulation of senescent OCYs can alter mesenchymal lineage commitment, subsequently inhibiting osteogenesis and promoting osteoclastogenesis, and ultimately leading to a bone homeostasis imbalance [
26,
27,
28]. These findings have revealed that increased senescent OCYs and their SASPs could be key etiological factors of the SIPS and bone damage associated with natural aging and premature aging syndromes, including radiotherapy, chemotherapy, and metabolic dysfunction, where they appear to mediate skeletal deterioration [
12]. It is worth noting that certain pivotal SASP factors can participate in an autocrine feedback loop, further amplifying the SASP signal [
29].
These SASP factors, which are heterogeneous and tissue-specific, mainly include proteins (such as interleukins, chemokines, and growth factors), bioactive lipids, small extracellular vesicles, and non-coding nucleic acids that can lead to multiple senescence-associated disorders by eliciting local and systemic consequences [
30]. As one of the key SASP factors that are secreted by senescent OCYs, CC chemokine ligand 3 (CCL3), initially known as macrophage inflammatory protein 1α (MIP-1α) [
31], is a pro-inflammatory cytokine that can activate the chemotaxis of T cells, B cells, and monocytes [
32]. It is also involved in the inflammatory process [
33] and the modulation of bone homeostasis. Firstly, CCL3 can inhibit osteoblast proliferation and osteogenic differentiation by binding to CCR1 and downregulating the expression of osteocalcin (OCN) [
34,
35], as well as promoting adipogenic differentiation [
35]. Additionally, as a potent osteoclast-activating factor (OAF) [
36], CCL3 can regulate the recruitment, migration, adhesion, and differentiation of osteoclast precursors, thereby promoting osteoclast formation in a direct or indirect manner [
37,
38]. However, it is not fully understood whether CCL3 plays an important role in IR-induced bone homeostasis imbalance associated with oxidative stress and cellular senescence.
To understand how bone homeostasis is damaged by IR, it is necessary to use several types of analysis, considering changes in distinct cellular alterations and their heterogeneous SASP in the bone microenvironment. The aim of the present study was to evaluate the effects of IR on OCYs, with a specific focus on IR-induced cellular senescence, aberrant secretion of SASP factors, and subsequent activation of cytokine cascades. Furthermore, this study aimed to elucidate the role of CCL3 in IR-mediated bone homeostasis disruption through SASP-mediated signaling pathways, particularly the PI3K/Akt/NF-κB axis. This research provides novel insights regarding the pathogenesis of cancer-treatment-induced bone loss (CTIBL), while laying the groundwork and providing experimental evidence for future research to identify new targets to treat IR-induced bone homeostasis imbalance.
2. Materials and Methods
2.1. Primary OCY Isolation and Identification
Primary OCYs were isolated from the calvaria of specific pathogen-free male BALB/c mice, adopting the protocol standardized in our laboratory [
39]. All animal procedures underwent ethical review and were sanctioned by the Experimental Animal Ethics Committee of School of Pharmacy Fudan University (approval code: 2024-02-FYS-ZGY-02, approved on 20 February 2024). In brief, six-week-old, male BALB/c mice (weighing 18–22 g) were purchased from Jihui Laboratory Animal Breeding Co. (Shanghai, China). The mice’s calvaria were aseptically extracted and fragmented, followed by sequential digestion using 0.25% Trypsin (25200072; Gibco, Eggenstein, Germany), 0.1% g/mL collagenase type II (C6885; Sigma-Aldrich, St. Louis, MO, USA), 0.05 mM EDTA (E1170; Solarbio, Beijing, China), and 0.1% g/mL collagenase type I (C0130; Sigma-Aldrich, St. Louis, MO, USA) at 37 °C. Subsequently, the bone fragments and supernatant were incubated in a humidified incubator at 37 °C and 5% CO
2. After 7 days of culture in vitro, the dendritic OCYs around bone fragments were visualized and subsequently identified as passage 0. The following experiments were conducted by utilizing passage 2–3 cells.
For the identification of primary OCYs, the indexes of alkaline phosphatase (ALP) stain and E11/gp38 marker protein were utilized. During the ALP staining, the cells were washed with PBS after removing the medium, fixed with 2.5% glutaraldehyde for 5 min, rinsed with PBS, and then incubated at room temperature on a shaker with an ALP staining solution, provided in the BCIP/NBT Alkaline Phosphatase Color Development Kit (C3206; Beyotime Institute of Biotechnology, Shanghai, China), for 1 h. For each well, images of 10 random view fields were taken at 100× magnification under a light microscope (Leica Microsystems, Weltzar, Germany). Furthermore, the mRNA and protein expression levels of the OCY marker protein E11/gp38 were detected by means of RT-qPCR and Western blot analysis, respectively. Primary osteoblasts (OBs), isolated according to the protocol established in our laboratory [
39], were detected simultaneously and utilized as controls. The detailed procedures of the RT-qPCR and Western blot analysis are described below.
2.2. Cell Culture and Irradiation
The cells were cultured in a humidified environment containing 5% CO2 at 37 °C. The culture medium consisted of an α-minimum essential medium (α-MEM) (C12571500BT; Gibco, Eggenstein, Germany) supplemented with 10% fetal bovine serum (FBS) (10099-141C; Gibco, Eggenstein, Germany), 100 μg/mL of penicillin-streptomycin (PS) (15140122; Gibco-Thermo Fisher, Waltham, MA, USA), and 5 μg/mL of plasmocinTM prophylactic (ant-mpp; Invivogen, San Diego, CA, USA). Once 30–40% confluence was reached after 24 h of culture, the cells were irradiated with 2 Gy of X-ray using an X-Rad 320 Biological Irradiator (X-RAD320; PXi, Houston, TX, USA). The irradiation parameters were set as follows: a tube voltage of 320 kV, tube current of 4.3 mA, source surface distance of 50.0 cm, and dose rate of 106.3 cGy/min. The control group was placed on the irradiator platform for an equivalent duration, but without undergoing irradiation treatment.
For experiments involving CCL3-neutralizing antibody treatment (AF-450; R&D Systems, Inc., Minneapolis, MN, USA), the irradiated OCYs were treated with 50 ng/mL of the antibody. The culture persisted for 72 h, with the culture medium being replaced every 2 days, and the neutralizing antibody was replenished every time the culture medium was changed.
2.3. IR-Induced Morphological Changes and Biological Impairments of OCYs In Vitro
2.3.1. Cell Counting Kit-8 (CCK8) Cell Viability Assay
The cell viability of the irradiated OCYs was assessed using a CCK8 assay. In brief, OCYs were seeded into 96-well plates (3 × 103 cells/well) and incubated for 24 h, then irradiated with 2 Gy of X-ray, followed by incubation for 1, 2, or 3 days. In parallel, OCYs were also irradiated at different levels of X-ray (0, 0.25, 0.5, 1, 2 Gy) to explore the dose-dependent effects of radiation on the cell viability. Following the incubation period, a CCK8 reagent (CK04; Dojindo, Kumamoto, Japan) was added to each well at a 10% concentration, and the plates were further incubated for 2 h at 37 °C. Finally, cell viability was determined by measuring absorbance at 450 nm using a microplate reader (Epoch™; Biotech, Vicenza, Italy).
2.3.2. 5-Ethynyl-2′-deoxyuridine (EdU) Cell Proliferation Assay
OCYs were seeded onto 3.5 cm coverslips placed in 6-well plates (2.5 × 105 cells/well) and cultured for 24 h, then irradiated with 2 Gy of X-ray, followed by incubation for 24 h. Then, cells were co-incubated with 10 μM of an EdU working solution for 2 h under 5% CO2 and 37 °C conditions. Following incubation, EdU fluorescence labeling was achieved using the EdU Cell Proliferation Kit (C0071S; Beyotime Institute of Biotechnology, Shanghai, China). The cell nuclei were stained with a Hoechst solution at room temperature in the dark. The proliferating cells fluoresced green, while the nuclei of all cells fluoresced blue. For each well, images of EdU-positive cells were obtained from 10 random fields at 200× magnification using a Nikon Ni-U compound fluorescence microscope equipped with a Nikon DS-Ri2 camera and the Nikon NIS-Elements Fr software (Nikon Instruments Inc., Melville, NY, USA). Cell counting was facilitated by ImageJ (1.54f; National Institutes of Health, Bethesda, MD, USA), and the percentage of EdU-positive cells was determined using the following formula: EdU-positive rate = (EdU-positive cell count/(EdU-positive cell count + EdU-negative cell count)) × 100%. This was used to visualize the cells’ ability to proliferate.
2.3.3. Morphological Alteration Assays
Specific dendrite-like synapses and cytoskeletal changes were examined using scanning electron microscopy (SEM) and staining procedures. The cells were seeded onto 3.5 cm coverslips placed in 6-well plates (1 × 105 cells/well). After being irradiated with 2 Gy of X-ray, the cells were incubated until they reached 60% confluence and then harvested. Following this, the cells were fixed with an electron microscope fixative (G1102; Servicebio, Wuhan, China) for 24 h at 4 °C. Subsequently, the harvested cells were post-fixed using 0.1 M of phosphate buffer (PH = 7.4), dehydrated through a gradient of ethanol, and coated with a conductive metal layer. They were then examined using a scanning electron microscope (SU8100; Hitachi, Tokyo, Japan) operating at an accelerating voltage of 3.00 kV. The SEM micrographs of the OCYs were obtained with 1500× magnification. Meanwhile, the cytoskeletal changes were observed by using tetramethyl rhodamine (TRITC)-phalloidin (CA1610; Solarbio, Beijing, China) to visualize F-actin, whereas 4′,6-diamino-2-phenylindole (DAPI) (D523; Dojindo, Kumamoto, Japan) was used to highlight the nuclei. Briefly, cells were fixed with 2.5% glutaraldehyde, incubated in the dark at room temperature for 1 h with 200 μL of TRITC-phalloidin working solution (diluted to 1:500), and re-stained for 30 s with 200 μL of DAPI solution (diluted to 1:500) in the dark. Ten random fields were selected in each well, and representative images were captured using a Nikon Ni-U compound microscope equipped with specific TRITC excitation–emission filters (Ex/Em = 540/570 nm) and DAPI excitation–emission filters (Ex/Em = 364/454 nm) at 200× magnification. The dendritic length of the OCYs was measured from randomly selected regions in each well using ImageJ.
2.4. DNA Damage and Repair Assays
2.4.1. DNA Damage Detection
The γ-H2AX foci, markers of DNA damage, were examined according to a previously described procedure [
40]. The procedures of immunofluorescence staining are described below in detail. γ-H2AX positivity was defined as nuclei containing ≥10 immunoreactive foci.
2.4.2. Cell Cycle and Apoptosis Analysis
The flow cytometry assay was performed to detect the cell cycle and apoptosis of the OCYs. The OCYs were seeded into T25 culture flasks (2.5 × 105 cells/flask) and cultured for 24 h, then irradiated with 2 Gy of X-ray and continued incubation for 72 h, and cell generation cycles and apoptosis were detected. The harvested cells were processed using the Cell Cycle Staining Kit (70-CCS012; Lianke Biotech, Hangzhou, China) and Annexin V-FITC/PI Apoptosis Detection Kit (AP101-30; Lianke Biotech, Hangzhou, China) according to the manufacturer’s instructions. In brief, 1 × 106 cells were collected and washed with PBS. Subsequently, 1 mL of DNA staining solution and 10 μL of permeabilization solution were added, and the mixture was vortexed and shaken for 5–10 s. After incubation for 30 min at room temperature in the dark, the lowest loading rate was selected to detect cell cycles. Likewise, 5 μL of Annexin V-APC and 10 μL of PI were added to detect apoptosis. Detection was carried out using a CytoFlex flow cytometer (CytoFLEX; Beckman Coulter, Inc., Fullerton, CA, USA). The cell cycle profiles were generated using ModFit LT (Version 5.0; verity Software House, Topsham, ME, USA). The cell apoptosis rate was determined using the following formula: cell apoptosis rate (%) = (apoptotic cell number/total cell number) × 100%.
2.5. Characteristic Senescence Phenotypes Assays
2.5.1. Senescence-Associated β-Galactosidase (SA-β-Gal) Staining
Briefly, the OCYs were seeded into 6-well plates (1 × 105 cells/well) and incubated for 24 h; then, the cells were irradiated with 2 Gy of X-ray and cultured for an additional 48 h. Following incubation, the cells were washed with PBS and fixed using a fixative solution for 15 min. Subsequently, the cells were incubated with freshly prepared SA-β-gal staining solution (C0602; Beyotime Institute of Biotechnology, Shanghai, China) at 37 °C overnight in a CO2-free environment. The number of SA-β-gal-positive cells per 200 cells was counted in randomly selected regions for each well, and the results were expressed as a percentage.
2.5.2. Senescence-Associated Heterochromatin Foci (SAHF) Detection
The SAHF, recognized as a DNase-resistant and DAPI-dense subnuclear structure, is believed to repress genes that promote proliferation, thus aiding in senescence-associated cell cycle arrest [
41]. To detect SAHF, cells were immobilized using 4% paraformaldehyde (P1110; Solarbio, Beijing, China) for 15 min. Following 3 washes with PBS, the immobilized cells were permeabilized using 0.1% Triton-X 100 for 10 min, washed again, and stained with DAPI in the dark at room temperature for 5 min. The proportion of SAHF-positive cells was determined by manually examining 200 DAPI-stained cells for each well, which were randomly selected from various regions and observed under a Nikon Ni-U compound microscope equipped with specific DAPI excitation–emission filters (Ex/Em = 364/454 nm) at 400× magnification.
2.5.3. Senescence-Related Gene and Protein Expression Assay
The expression levels of the key senescence marker genes p16 and p21 were detected by means of Western blot and RT-qPCR, respectively. The procedures are described in detail below.
2.5.4. SASP Marker Detection
The supernatant from the OCYs was collected and detected using the Mouse XL Cytokine Array kit (Cat ARY028; R&D Systems, Inc., Minneapolis, MN, USA) and enzyme-linked immunosorbent assay (ELISA) kit (Enzyme-Linked Biotechnology, Shanghai, China) according to the manufacturer’s instructions. First, a total of 111 different cytokines in the supernatant of the cultured OCYs were measured by means of a cytokine antibody microarray. The dot blot membranes were developed utilizing an enhanced chemiluminescence horseradish peroxidase (HRP) substrate. Data were analyzed using the ImageJ software, and the expression (pixel density) was normalized between membranes using positive and negative reference spots on each membrane. Subsequently, the ELISA procedure was utilized to verify the main pro-inflammatory secretory factors. The procedure involved several steps: firstly, 50 µL standard solution with different concentrations and a 50 µL sample were added to blank, standard, or sample wells. Next, 100 µL of HRP-labeled detection antibody was added to each well, except the blank wells. Afterwards, the reaction plate was sealed and incubated at 37 °C for 1 h. After the liquid was discarded, the wells were filled with a washing solution and then repeatedly left to stand for 30 s, emptied, and shaken 5 times. Finally, 50 µL of substrate A and 50 µL of substrate B were added to every well, and the wells were incubated in the dark at 37 °C for 15 min; then, 50 µL of termination solution was added to each well and the absorbance was measured at 450 nm using a microplate reader. The sample concentration was determined using a standard curve based on the measured OD values of the standards.
2.6. Regulation of Osteogenesis by CCL3 Secreted from IR-Induced Senescent OCYs
2.6.1. Conditioned Medium (CM) Collection
The OCYs were seeded into T75 flasks (Nunc; Thermo Fisher Scientific, Bagsværd, Denmark) at a density of 1 × 106. After 24 h, the cells were irradiated with 2 Gy of X-ray and left to incubate for 24 h. The OCYs were then further incubated in a fresh volume of serum-free α-MEM for 24 h, and the culture supernatant was gathered, filtered using a 0.22 μm suction filter, and designated as the conditioned medium (CM). Supernatants derived from non-irradiated and irradiated OCYs were labeled as 0 Gy-CM and 2 Gy-CM, respectively, and stored at –80 °C for future co-culture experiments. For experiments involving a CCL3-neutralizing antibody treatment, the irradiated OCY supernatants were treated with 50 ng/mL of the antibody and labeled as 2 Gy-CM + anti-CCL3.
2.6.2. Isolation of Bone-Marrow-Derived Mesenchymal Stem Cells (BMSCs)
Primary BMSCs were isolated from 3-week-old male SD rats. Euthanasia was performed via intraperitoneal injection of an anesthetic, followed by the careful separation of the femur and tibia. Total bone marrow cells were then obtained using a previously established method [
42]. The sedimented cells were resuspended in α-MEM and subsequently inoculated into T25 flasks. Following incubation in a humidified incubator at 37 °C with 5% CO
2 for 48 h, the adherent cells were collected as BMSCs.
2.6.3. Colony-Forming Unit (CFU) Assay
The BMSCs (passage 3) were seeded at a density of 2 × 103 cells into 6 cm Petri dishes. Following a 24 h affixation period to the dish walls, the culture medium was replaced with α-MEM containing 50% CM (0 Gy, 2 Gy, or 2 Gy + anti-CCL3). After 2 weeks of co-culture, cell colonies became visible. These colonies were fixed with methanol for 15 min and stained with crystal violet (C8470; Solarbio, Beijing, China) for an additional 10 min. The colony-forming unit (CFU) was calculated by comparing the number of colonies to the total number of seeded cells in each dish.
2.6.4. Osteogenic Differentiation Potential Assay
The BMSCs (passage 3) were seeded into 48-well plates (3 × 104 cells/well) and subsequently cultured in an osteogenic induction medium comprising α-MEM enriched with 15% FBS, 1% PS, 50 mg/L ascorbic acid, 0.1 µM dexamethasone (ST1254; Beyotime Institute of Biotechnology, Shanghai, China), and 10 mM β-glycerophosphate (50020; Sigma-Aldrich, St. Louis, MO, USA). Additionally, the medium was replaced with α-MEM containing 50% CM (0 Gy, 2 Gy, and 2 Gy + anti-CCL3), which was substituted with a fresh medium at 48 h intervals. After 7 days of osteogenic induction, the cells were immobilized using 2.5% glutaraldehyde for 15 min, rinsed thrice with PBS, and subsequently stained with the BCIP/NBT Alkaline Phosphatase Color Development Kit according to the manufacturer’s instructions. In addition, the mineralized nodule formation was measured in order to evaluate the in vitro mineralization ability. After 21 days of osteogenic induction, alizarin red staining was employed to quantify the mineralized nodules. Specifically, the cells were immobilized in 95% ethanol for 10 min, subsequently exposed to a 0.2% alizarin red S staining solution (0.2%, pH 8.3) (C0140; Beyotime Institute of Biotechnology, Shanghai, China), and incubated at 37 °C for 1 h. After flushing with PBS, the positively stained nodule areas in each group were measured from randomly selected regions for each well using ImageJ, and the results were presented as the area percentage of positive alizarin red staining.
2.7. Regulation of Osteoclastogenesis by CCL3 Secreted from IR-Induced Senescent OCYs
2.7.1. Conditioned Medium (CM) Collection
The detailed processes for CM collection of senescent OCYs are described above.
2.7.2. Isolation of Bone-Marrow-Derived Macrophages (BMMs)
BMMs were isolated from 6-week-old male BALB/c mice using two-step Ficoll density gradient sedimentation [
43]. Briefly, the lymphocyte separation medium (17544602; Cytiva, Dorset, UK) was placed in the centrifuge tube, followed by the slow addition of an equal volume of whole bone marrow cell suspension. After centrifuging at 20 °C and 2500 rpm for 30 min, the middle layer was transferred to a fresh centrifuge tube, mixed with sterile PBS, and centrifuged at 20 °C and 1000 rpm for 10 min. Subsequently, the collected cells were resuspended in a complete medium and inoculated into T25 flasks. Following a 24 h incubation period at 37 °C and 5% CO
2, the supernatant was discarded after being centrifuged at 20 °C and 1000 rpm for 10 min. Finally, cells were resuspended in a complete medium supplemented with 25 ng/mL of macrophage colony-stimulating factor (M-CSF) (315-02; Peprotech, Rocky Hill, NJ, USA) and inoculated in 96-well plates for 72 h.
2.7.3. Migration and Invasion Ability of Osteoclast Precursors (OCPs)
The horizontal migration of OCPs was evaluated using the wound healing scratch assay, while their vertical migration was assessed using a trans-well assay in vitro. For the wound healing assay, the BMMs were seeded into 6-well plates (4 × 105 cells/well) and incubated in a complete medium enriched with 25 ng/mL of M-CSF. After confluence, the cells were treated with mitomycin (1 μg/mL) (M5353; Sigma-Aldrich, St. Louis, MO, USA) for 1 h, and then a straight scratch was made in the cell monolayer using a 200 µL pipet tip, immediately followed by washing and incubation in a serum-free medium containing 50% CM (0 Gy, 2 Gy, or 2 Gy + anti-CCL3). After 24 h of culture, the number of cells that had migrated from the wound edge was quantified. For the trans-well assay, the BMMs (2 × 105 cells/well) were cultured in the upper chamber of a trans-well plate in 200 µL of α-MEM with 25 ng/mL of M-CSF for 48 h and then replenished with serum-free α-MEM. Subsequently, 1 mL of α-MEM containing 50% CM (0 Gy, 2 Gy, or 2 Gy + anti-CCL3) was added into the lower chambers, and cells were incubated for an additional 24 h. Following this, the cells in the lower chamber which had migrated from the upper chamber were fixed with 2.5% glutaraldehyde for 5 min and stained with crystal violet for 10 min. Ten random images per well were captured under a light microscope at 100× magnification, and the average number of stained positive cells was calculated.
2.7.4. Tartrate-Resistant Acid Phosphatase (TRAP) Staining
The BMMs were seeded into 96-well plates (2 × 104 cells/well) and incubated in a complete medium enriched with 25 ng/mL of M-CSF for 72 h. Subsequently, the medium was substituted with an osteoclast induction-conditioned medium consisting of 50% CM (0 Gy, 2 Gy, or 2 Gy + anti-CCL3) and was further fortified with 25 ng/mL of M-CSF and 10 ng/mL of receptor activator of nuclear factor kappa-B ligand (RANKL) (315-11; Peprotech, Rocky Hill, NJ, USA). After a 4–5 day induction phase, the osteoclasts were immobilized and stained using the TRAP kit (387A-1KT; Sigma-Aldrich, St. Louis, MO, USA) according to the manufacturer’s guidelines. Cells with positive TRAP staining and more than 5 nuclei were enumerated as osteoclasts.
2.7.5. Bone Resorption Capacity Assay
The BMMs were resuspended in an α-MEM medium enriched with 25 ng/mL of M-CSF and then evenly distributed onto a 96-well osteoclast activity detection plate (2 × 104 cells/well), which had been pre-coated with a thin layer of inorganic three-dimensional crystal material (3989; Corning, NY, USA). Adherent cells were cultured for 3 days, the osteoclast induction-conditioned medium was replaced, and the incubation was continued for 10 days. Subsequently, the induction solution was discarded, and the cells were washed twice with PBS buffer, lysed with 5% sodium hypochlorite (80010428; Sinopharm Chemical Reagent Co., Shanghai, China) for 10 min, rinsed 3 times with distilled water, and then dried at room temperature for 2 h. The bone resorption pits were captured at 40× magnification, and the pit areas were analyzed using ImageJ.
2.7.6. Cytoskeletal Alteration Assay
The cytoskeletal alteration was examined through staining procedures, and TRITC-phalloidin was used to visualize F-actin, whereas DAPI was used to highlight the nuclei. The detailed methods are described above.
2.7.7. Osteoclastogenic Function-Related Gene Expression
The expression levels of the osteoclastogenic function-related genes were detected by means of RT-qPCR, and the methods are described in detail below.
2.8. RNA Sequencing and Transcriptome Analysis
High-throughput RNA sequencing (RNA-seq) and transcriptome analysis were performed by Gene Denovo Biotechnology Co., Ltd. (Guangzhou, China), following previously reported protocols [
44]. In brief, total RNA was extracted from the primary OCYs treated with 2 Gy X-ray (IR) and 0 Gy X-ray (Ct) using a TRIzol
TM reagent (15596018; Invitrogen, CA, USA). The concentration and purity of the extracted RNA were examined using a NanoPhotometer spectrophotometer and agarose gel electrophoresis. The cDNA library was prepared from the reverse-transcribed cleaved RNA fragment standards according to the protocol of Illumina (Illumina, San Diego, CA, USA). The paired-end sequencing of cDNA was performed on the Illumina NovaSeq X Plus. Clean reads from 6 transcriptomes were obtained by removing low-quality data and adaptor sequences, which were then mapped to the genome of Balb/c mice for transcript reconstruction. To identify differentially expressed genes (DEGs), |log
2 fold change (FC)| > log
2(1.5) and P value < 0.05 were set as the statistically significant criteria. Furthermore, the DESeq2 analysis encompassed a total of 21,480 genes, consisting of 20,449 reference genes and 1,031 novel genes. The bioinformatic analysis was conducted on the Omicsmart platform (Available online:
https://www.omicsmart.com/, assessed on 8 February 2025).
2.9. RNA Extraction and RT-qPCR Assay
Total RNA was extracted using the Simply P Total RNA Extraction Kit (BSC52S1; Bioflux, Beijing, China) according to standard protocols. RNA was then reverse-transcribed with the FastKing gDNA Dispelling RT SuperMix (KR118-02; Tiangen Biotech, Beijing, China). The SYBR Green-based RT-qPCR was performed on the ABI QuantStudio 5 (Applied Biosystems, Carlsbad, CA, USA) utilizing a PowerUp SYBR Green Master Mix (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) in a 10 µL reaction volume according to the manufacturer’s protocol. Samples were normalized to the level of GAPDH mRNA and expressed as relative units. The primer sequences of the target genes are listed in
Table 1.
2.10. Western Blot Analysis
The cells were lysed using a RIPA lysis buffer (P0013B; Beyotime Institute of Biotechnology, China) containing protease inhibitors (ST506; Beyotime Institute of Biotechnology, China) and then placed on ice for 40 min. After lysates were harvested by means of centrifugation at 12,000× g for 15 min at 4 °C, the total cellular protein concentrations were quantified using the BCA Protein Assay Kit (P0012; Beyotime Institute of Biotechnology, Shanghai, China) according to the manufacturer’s instructions. The protein (25–40 µg) was subjected to different SDS–polyacrylamide gel electrophoresis (Epizyme Biotech, Shanghai, China) procedures according to its molecular weight and transferred onto 0.2 μm polyvinylidene difluoride (PVDF) membranes (ISEQ00010; Millipore, Billerica, MA, USA). The whole membranes were blocked with 5% skim milk (P0216; Beyotime Institute of Biotechnology, Shanghai, China) or 5% BSA (ST025; Beyotime Institute of Biotechnology, Shanghai, China) for 1 h at room temperature; then, immunoblotting was conducted with primary antibodies (diluted to 1:1000) as follows: E11 (ab11936; Abcam, Cambridge, UK), γ-H2AX (ab81299; Abcam, Cambridge, UK), p16 (ab51243; Abcam, Cambridge, UK), p21 (ab109199; Abcam, Cambridge, UK), CCL3 (AF-450; R&D Systems, Inc., Minneapolis, MN, USA), PI3K (4257; Cell Signaling Technology, Inc., Danvers, MA, USA), P-PI3K (4228; Cell Signaling Technology, Inc., Danvers, MA, USA), Akt (4691; Cell Signaling Technology, Inc., Danvers, MA, USA), P-Akt (4060; Cell Signaling Technology, Inc., Danvers, MA, USA), NF-κB/p65 (8242; Cell Signaling Technology, Inc., Danvers, MA, USA), P-NF-κB/P-p65 (3033; Cell Signaling Technology, Inc., Danvers, MA, USA), and β-actin (13E5, Cell Signaling Technology, Inc., Danvers, MA, USA). After incubation overnight at 4 °C, the membranes were washed and incubated with anti-rabbit or anti-mouse IgG-HRP conjugated antibodies (SA00001-2; SA00001-1; diluted to 1:2000, Proteintech, Wuhan, China) for 1 h at room temperature. Immunoreactive bands were ultimately detected through the use of an ECL Kit (D3308; Beyotime Institute of Biotechnology, Shanghai, China) in conjunction with an Omega Lum™ C Imaging System (Gel Company, San Francisco, CA, USA). The quantitative analysis was carried out using ImageJ, and β-actin was used to normalize the expression of protein levels.
2.11. Immunofluorescence Staining
The cells were fixed with 4% cold paraformaldehyde for 15 min and permeabilized with 0.1% Triton-X100 for 10 min at room temperature. Samples were then blocked with 0.2% BSA in PBS and incubated with antibodies (diluted to 1:250) that target γ-H2AX and NF-κB/p65 overnight at 4 °C. Subsequently, the cells were incubated with FITC-labeled goat anti-rabbit IgG (H+L) (diluted to 1:500, A0562; Beyotime Institute of Biotechnology, Shanghai, China) for 2 h in the dark, and their nuclei were stained with DAPI for 5 min. Ten random fields in each well from both the control and treatment groups were captured to observe the γ-H2AX positivity and nuclear translocation of NF-κB/p65 using a Nikon Ni-U compound microscope at 200× magnification.
2.12. Statistical Analysis
The statistical analysis and graphic generation were performed using IBM SPSS Statistics (Version 22; IBM Corporation, Armonk, NY, USA) and GraphPad Prism (Version 8.0; GraphPad Software, Inc., San Diego, CA, USA), respectively. Heatmap with cluster analysis was constructed with Origin (Version 2022; originLab, Northampton, MA, USA). All experimental data are presented as mean ± standard deviation (SD). If the data followed a normal distribution and met homogeneity of variance, statistical differences between two groups were assessed using an independent samples t-test, or one-way analysis of variance (one-way ANOVA) was used for multiple groups. During the one-way ANOVA analysis, Tukey’s multiple comparison test was further used for comparison between the two groups. When the data did not conform to a normal distribution, a nonparametric test was performed.
4. Discussion
Cancer treatment-related bone loss (CTIBL) is of high concern as a notable radiotherapy complication that restricts the prognosis of cancer patients, and further contributes to an elevated risk of fracture and bone metastases. Additionally, the combined impact of SIPS and physiological aging in tumor-prone age groups may bring about substantial imbalances in the reconstruction of both irradiated and distant skeletal sites [
2,
3,
4,
8]. Targeting paracrine regulation in senescent OCYs could potentially offer novel research avenues and targets for the prevention and treatment of complications arising from cancer radiotherapy.
As the most abundant long-lived terminally differentiated cells within the bone matrix, OCYs play a crucial role in maintaining skeletal homeostasis, participate in mechano-transduction, and secrete endocrine signals that mediate various organ functions [
17,
18,
19]. The multi-dendritic structure of OCYs plays a pivotal role in their physiological function, facilitating signal communication between OCYs and other cells on the bone surface. Given that OCYs exhibit heightened vulnerability to stress factors, like hypoxia and reactive oxygen species, and face more stringent conditions for nutrient storage, they are prone to direct biological impairment when exposed to microcirculation disorders and oxidative stress triggered by IR [
51]. In this study, we adopted a modified sequential digestion method to isolate primary OCYs from mouse calvaria for in vitro experiments. The isolated OCYs showed a dendritic morphology, were negative for ALP expression, and were positive for the E11 antigen. To assess the potential damage of IR on the biological function of OCYs, primary OCYs were exposed to a gradient of X-ray doses in vitro. Our findings revealed a notable decrease in cell viability, particularly under 2 Gy irradiation, along with a significant reduction in their proliferative capacity. Additionally, morphological alterations were observed, including synapse shortening, morphological alterations, and blurred boundaries. The viability and proliferative capacity of cells are crucial for maintaining the biological function of OCYs. These results indicate that IR can result in a decrease in OCYs’ viability and proliferative capacity, thereby impacting their biological function. This provides a crucial cytological foundation for understanding the bone homeostasis imbalance that follows irradiation.
IR can trigger cycles and cascades of oxidation/reduction reactions, which may be beneficial for restoring normal physical function and suppressing tumor growth. However, it can also cause acute DNA damage, leading to cell cycle arrest; DNA repair; and apoptosis, senescence, autophagy, and other cellular responses, which are mediated by interactions between p53 and transcriptional cofactors [
6,
11]. To clarify whether IR can induce DNA damage in OCYs, further investigations of a characteristic protein marker for the identification DNA damage were conducted in this study [
47]. The results revealed a significant amount of clustered DNA double-strand breaks and γ-H2AX accumulation in the irradiated OCYs through immunofluorescence and Western blot analyses. These findings suggest that IR can induce DNA double-strand breaks in OCYs. To analyze the persistence of this damage, further examination of the cell cycle and apoptosis was conducted. Notably, a remarkable increase in the number of G2/M-phase cells was observed after exposure to 2 Gy irradiation, implying that DNA damage induced by IR could trigger cell cycle checkpoints, allowing for additional time for cellular repair mechanisms to address the damage [
52,
53]. Moreover, the concurrent decrease in cell proliferation and increase in cell apoptosis of the irradiated OCYs suggested that the DNA damage may not have been fully repaired.
IR-induced cellular senescence is a process in which cells that have been exposed to X-ray irradiation undergo changes in their function and structure, resulting in a permanent halt in the cell cycle, which is typically accompanied by reduced cell proliferation [
7,
14,
54]. Previous studies have primarily focused on how IR triggers cell apoptosis or death in OCYs. However, recent research indicates that cells that have evaded apoptosis or death can profoundly impact the outcomes of bone injury and its prognostic regression. This may be attributed to an intermediate state known as minority mitochondrial outer-membrane permeabilization (miMOMP) [
55]. Specifically, when cells are exposed to sub-lethal stress conditions, a small subset of mitochondria within them experience MOMP. The occurrence of this phenomenon, rather than cell death, may initiate the release of mitochondrial DNA (mtDNA) into the cytoplasm. The released mtDNA then activates the cGAS-STING pathway, ultimately leading to the induction of SASP. Notably, even a small proportion of senescent cells, ranging from 10% to 15% of the total cell volume, is adequate to cause tissue dysfunction in aged primates [
56,
57]. However, the identification of cellular senescence remains challenging due to the diverse characteristics of senescent cells [
58]. Consequently, there is no single biomarker for their detection, necessitating the combination of multiple indicators to conduct a comprehensive assessment [
14,
15]. In this study, distinct senescence indicators in post-irradiation OCYs were observed by employing multiple senescence detection indexes, including (a) increased SA-β-gal activity, (b) transcriptional upregulation and concomitant protein accumulation of the the cyclin-dependent kinase inhibitors P16 (CDKN2A) and P21 (CDKN1A), and (c) an enhanced proportion of SAHF-positive cells. Notably, the increase in SAHF-positive cells was correlated with changes in the chromatin structure of the OCYs, indicating an irreversible decline in the OCYs’ proliferative and DNA-replication capabilities [
41,
59]. These findings imply that exposure to 2 Gy irradiation could cause DNA damage in OCYs, subsequently triggering cellular senescence under stressful conditions. Furthermore, it is notable that the expression levels of two autophagy-related genes, Atg7 and LC3, exhibited a downward trend in the OCYs following irradiation. The preservation of functional autophagy is pivotal for maintaining cellular and tissue health, whereas a decrease in autophagy levels is frequently associated with the initiation of cellular senescence [
60]. This finding implies a possible mechanism involving autophagy in the onset of cellular senescence induced by IR.
SASPs represent a distinctive secretome that is generated by senescent cells, encompassing various components such as pro-inflammatory cytokines, growth factors, chemokines, reactive oxygen species, metabolites, and matrix metalloproteinases [
14,
15,
16]. SASPs can initiate inflammation via autocrine and paracrine signaling, exacerbate cellular telomere dysfunction, and accelerate cellular senescence [
13,
15]. Recent studies indicate that SASPs exhibit intricate biological characteristics and bidirectional effects, which are not solely detrimental [
30,
61,
62]. This understanding underscores the urgency of unraveling the key regulators of SASP secretion and identifying novel targets for clinical prevention and treatment strategies. To thoroughly investigate the changes in SASPs and identify crucial regulatory mechanisms, a high-throughput proteomics antibody microarray was employed to assess the levels of 111 secreted protein factors in the supernatants of the irradiated OCYs. Heatmap and statistical analyses revealed a notable increase in the secretion of SASPs in the culture supernatants of the irradiated OCYs. Furthermore, RT-qPCR and ELISA were used to validate the expression levels of specific SASP factors. These additional analyses provided evidence that IR-induced senescent OCYs exhibit the overexpression and oversecretion of SASPs. Concurrently, based on in vitro cellular experiments and differential gene screening via RNA sequencing, we prioritized the chemokine (C-C motif) ligand 3 (CCL3), a significant SASP factor that is secreted by IR-induced senescent OCYs. The upregulation of the CCL3 gene and protein expression was further verified, as was the enhanced exocytosis level through RT-qPCR, Western blot analysis, and ELISA. The above results unequivocally demonstrated that irradiation can stimulate a remarkable increase in CCL3 secretion in senescent OCYs.
It has been found that aging is associated with OCY dysfunction, while a degradation of the OCY lacunar–myelin network has been observed in both older adults and senescent animal models [
24,
25]. Furthermore, the accumulation of senescent OCYs may disrupt the osteogenic differentiation potential of BMSCs and promote the generation of OCs, leading to bone homeostasis imbalance [
26,
27,
28]. Senescent OCYs and their SASPs have been shown to be associated with age-related bone loss [
23]. The results of this study demonstrated that the co-culture of BMSCs with CM from senescent OCYs could significantly inhibit their osteogenic differentiation ability; meanwhile, the co-culture of osteoclast precursor cells with CM from senescent OCYs could significantly promote their osteoclastic differentiation potential and resorption activity. When a CCL3-neutralizing antibody was added to the CM, it was found to be effective in reversing the negative regulation of the IR-induced senescent OCYs on both osteogenic differentiation and osteoclastic differentiation. This suggests that CCL3 hyper-secretion may play a critical regulatory role in IR-induced bone homeostasis imbalance.
It has been demonstrated in an aged mice model that CCL3 can inhibit the osteogenic differentiation potential of BMSCs by blocking ERK-activated DKK1-upregulation-mediated β-catenin activity [
35], which is consistent with our in vitro results. As for osteoclastogenesis, the results of the CCL3-neutralizing antibody intervention experiments provided evidence that enabled us to identify the role of CCL3 in excessive IR-induced osteoclastogenesis. Notably, the expressions of the autophagy-related genes
Atg7 and
Map1lc3a were also upregulated after the co-culture of the osteoclast precursor cells with CM from senescent OCYs, whereas the expression of autophagy-related genes was significantly reduced following the addition of the CCL3-neutralizing antibody. Previous studies have found that autophagy plays an important role in inflammation-mediated osteoclastogenesis hyperactivity, and a possible mechanism of this is that inflammatory factors can activate autophagy within OCs, thereby promoting the generation of OCs [
63]. In addition to affecting osteoclastogenesis, autophagy also influences the osteoclast resorption function during osteolysis. Li et al. [
64] found that knocking down
Atg5 and
Atg7 in OCs significantly reduced the amount of bone resorption pits, and the ability of lysosomes to migrate to the ruffled border was diminished, which may be due to the impaired membrane formation and extension of autophagosomes, resulting in decreased cellular degradation and phagocytosis. These results suggest that deleting CCL3 may decrease inflammatory factor secretion, ultimately suppressing cellular autophagy in OCs and counterbalancing excessive osteoclastogenesis and bone resorption activity.
The PI3K/Akt/NF-κB pathway plays a key role in a variety of physiological and pathological processes, including tumorigenesis, immunomodulation, and inflammation [
65,
66,
67]. The binding of CCL3 to its receptor, CCR5, can lead to the activation of PI3K through the activation of G protein-coupled receptors (GPCRs), while the activated PI3K can catalyze the conversion of phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-trisphosphate (PIP3) on the cell membrane, which in turn activates Akt. Akt can interact with these phospholipids, leading to its translocation to the inner membrane, where it is phosphorylated and activated by phospholipid-dependent kinase 1 (PDK1) and phospholipid-dependent kinase 2 (PDK2); ultimately, the function of these substrates could be regulated by activated Akt [
50]. This process plays a key role in several inflammation-related diseases but has rarely been reported in IR-induced inflammatory activation in OCYs. Taking into consideration CCL3’s dual regulatory function in osteogenesis and osteoclastogenesis, this study specifically emphasizes its crucial role. Furthermore, RNA-seq analyses revealed a notable upregulation of CCL3 gene expression in senescent OCYs, concurrent with the activation of the PI3K/Akt/NF-κB signaling pathway. Our Western blot analysis similarly demonstrated a notable increase in the phosphorylation of the PI3K, Akt, and NF-κB (p65) proteins. Importantly, the application of a CCL3-neutralizing antibody reduced the overexpression of hyperphosphorylated proteins, suggesting that CCL3 may directly influence the activation of this signaling cascade. Under physiological conditions, the NF-κB complex is in an inactivated state, because it binds to the inhibitor IκB. Phosphorylated IKK can degrade IκB so that the NF-κB complex is released and ectopically translocated to the nucleus, which regulates the expression of genes and the secretion level of SASPs through transcription factors. The nuclear translocation of NF-κB was further examined in this study, and it was found that 2 Gy irradiation could promote the translocation of NF-κB to the nucleus, thereby upregulating the expression of pro-inflammatory factors. In contrast, the nuclear translocation of p65 in the irradiated OCYs was inhibited by the CCL3-neutralizing antibody. Based on the above findings, we speculate that the activation of CCL3 may trigger a cascade amplification effect, creating a positive feedback loop of CCL3 autocrine production between the CCL3 and the PI3K/Akt/NF-κB signaling pathways, which further promotes IR-induced bone homeostasis imbalance. Furthermore, in vivo irradiation experiments are necessary to validate the findings of this study and ensure that they accurately reflect physiological conditions and simulate clinical radiotherapy scenarios. The results of the animal experiments were expected to confirm the clinical relevance of this study, as hypothesized.
Although our study has identified CCL3 as a pivotal component of the SASP secreted by IR-induced senescent OCYs, several other crucial factors that contribute to IR-induced bone homeostasis disruptions deserve further exploration. Additionally, our research merely establishes experimental evidence and the foundation for identifying novel targets to treat IR-induced imbalances in bone homeostasis. Considerable work remains to be done before achieving clinical applications. Moreover, to gain a deeper understanding of the precise mechanisms facilitated by CCL3, it is essential to specifically incorporate anti-CCL3-treated samples into RNA-seq analysis.